simvastatin has been researched along with Community Acquired Infection in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dancer, RCA; Greenwood, HL; Hazeldine, J; Lord, JM; Nightingale, P; Parekh, D; Patel, JM; Sadhra, C; Sapey, E; Thickett, DR; Walton, GM | 1 |
Dancer, RC; Greenwood, H; Khiroya, H; Mahida, R; Parekh, D; Patel, J; Sapey, E; Thickett, DR; Wang, Q | 1 |
CarratalĂ , J; Dorca, J; Garcia-Vidal, C; Llopis, F; Mestre, M; Morandeira-Rego, F; Simonetti, AF; Viasus, D | 1 |
3 trial(s) available for simvastatin and Community Acquired Infection
Article | Year |
---|---|
Pulmonary Infections in the Elderly Lead to Impaired Neutrophil Targeting, Which Is Improved by Simvastatin.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Community-Acquired Infections; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immune System Diseases; Leukocyte Disorders; Male; Middle Aged; Respiratory Tract Infections; Sepsis; Simvastatin | 2017 |
Simvastatin to modify neutrophil function in older patients with septic pneumonia (SNOOPI): study protocol for a randomised placebo-controlled trial.
Topics: Administration, Oral; Age Factors; Aged; Anti-Inflammatory Agents; Biomarkers; Clinical Protocols; Community-Acquired Infections; England; Extracellular Traps; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Middle Aged; Neutrophils; Pneumonia, Bacterial; Reactive Oxygen Species; Research Design; Sepsis; Simvastatin; Time Factors; Treatment Outcome | 2014 |
The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Analysis of Variance; C-Reactive Protein; Community-Acquired Infections; Cytokines; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Length of Stay; Male; Middle Aged; Oxygen; Partial Pressure; Pneumonia; Prospective Studies; Simvastatin; Spain | 2015 |